Comparison of Monoclonal Gammopathies Linked to Poliovirus or Coxsackievirus vs. Other Infectious Pathogens

脊髓灰质炎病毒或柯萨奇病毒相关单克隆丙种球蛋白病与其他传染性病原体相关单克隆丙种球蛋白病的比较

阅读:1
作者:Jean Harb ,Nicolas Mennesson ,Cassandra Lepetit ,Maeva Fourny ,Margaux Louvois ,Adrien Bosseboeuf ,Sophie Allain-Maillet ,Olivier Decaux ,Caroline Moreau ,Anne Tallet ,Eric Piver ,Philippe Moreau ,Valéry Salle ,Edith Bigot-Corbel ,Sylvie Hermouet

Abstract

Chronic stimulation by infectious pathogens or self-antigen glucosylsphingosine (GlcSph) can lead to monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma (MM). Novel assays such as the multiplex infectious antigen microarray (MIAA) and GlcSph assays, permit identification of targets for >60% purified monoclonal immunoglobulins (Igs). Searching for additional targets, we selected 28 purified monoclonal Igs whose antigen was not represented on the MIAA and GlcSph assays; their specificity of recognition was then analyzed using microarrays consisting of 3760 B-cell epitopes from 196 pathogens. The peptide sequences PALTAVETG and PALTAAETG of the VP1 coat proteins of human poliovirus 1/3 and coxsackievirus B1/B3, respectively, were specifically recognized by 6/28 monoclonal Igs. Re-analysis of patient cohorts showed that purified monoclonal Igs from 10/155 MGUS/SM (6.5%) and 3/147 MM (2.0%) bound to the PALTAVETG or PALTAAETG epitopes. Altogether, PALTAV/AETG-initiated MGUS are not rare and few seem to evolve toward myeloma. Keywords: MGUS; antigen specificity; coxsackievirus; infection; monoclonal gammopathy; monoclonal immunoglobulin; multiple myeloma; pathogen; poliovirus.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。